Hidden lung threat in cystic fibrosis: nationwide hunt for silent bacteria

NCT ID NCT03312075

Summary

This study aimed to understand how common and serious infections from non-tuberculous mycobacteria (NTM) are in people with cystic fibrosis in France. Researchers observed 848 patients to measure how many had these bacteria in their lungs and tested a new blood test to detect past exposure. The goal was to gather better information to help doctors diagnose and manage these complex infections in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AP-HP Hôpital Cochin

    Paris, 75679, France

  • AP-HP Hôpital Foch

    Suresnes, 92151, France

  • CHIC Créteil

    Créteil, 94000, France

  • CHR Sud Réunion

    Saint-Pierre, 97410, France

  • CHRU Brest

    Brest, 29200, France

  • CHU Amiens

    Amiens, Amiens, 80054, France

  • CHU Bordeaux

    Pessac, 33604, France

  • CHU Côte de Nacre

    Caen, 14033, France

  • CHU Grenoble

    Grenoble, 38043, France

  • CHU Lille

    Lille, 59037, France

  • CHU Rouen

    Rouen, 76031, France

  • CHU Toulouse

    Toulouse, 31059, France

  • CHU Tours

    Tours, 37044, France

  • Centre de Perharidy

    Roscoff, 29684, France

Conditions

Explore the condition pages connected to this study.